Kumamoto University Hospital

Site:	Kumamoto University Hospital
Address:
City:	Kumamoto
State:
Zip:	860-8556
Country:	Japan

Phase	Trial	Trial Status	Site Status	Drug	NCT#
1	A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)	Recruiting	Active	Pimitesib	NCT05245968
3	Study of Regorafenib as a 3rd-line or Greater Treatment for Gastrointestinal Stromal Tumors (GIST) (GRID)	Ongoing, but not recruiting	Closed	Regorafenib (BAY 73-4506)	NCT01271712
3	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)	Completed	Closed	Nilotinib or Imatinib	NCT00785785